Articles tagged with Transplantation
Two studies found a significant increase in five- and ten-year survival rates for MM patients over the past decade, with younger patients showing the most dramatic improvement. Novel therapies have been credited with this trend, particularly among younger patients.
A recent study published in Hepatology found that minority patients do not have worse outcomes after liver transplantation when treated at high-volume academic medical centers. The study, led by W. Ray Kim, analyzed data from over 2,800 adult patients and found no relationship between recipient race and survival.
Researchers found beta blockers to be more effective and safer than banding in reducing the risk of variceal bleeding in cirrhotic patients. The study, published in Liver Transplantation, compared the two treatments and found that beta blockers lowered the risk of bleeding by over 90%, while banding reduced the risk by less than 70%.
Researchers found that immunosuppressive drugs suppress beta-cell regeneration in diabetic mice, casting doubt on long-term islet transplantation success. This could lead to breakthroughs in regenerative islet transplantation and improved treatment for type 1 diabetics.
Researchers at Nottingham University have identified antibodies that can prevent infection with various strains of Hepatitis C virus in laboratory models. This breakthrough could lead to the development of a vaccine, which would significantly improve healthcare benefits for those suffering from hepatitis.
A Japanese patient with liver cirrhosis and HCV infection underwent liver transplantation and was cleared of the virus just one month later. The long-term use of PEGylated IFN may have contributed to this outcome.
Advanced age does not increase risk of death following liver transplant, according to a study. The authors analyzed 26 variables related to the recipients and found that preoperative hospitalization, cirrhosis caused by hepatitis C, and increasing model for end-stage liver disease (MELD) score were associated with higher death rates.
Two studies have found significant gender-based differences in newborns' hearts and livers that may explain why female infant deaths are higher after heart surgery and pediatric liver transplants are less successful. Newborn girls' hearts accumulate more acid during ischemia, which may lead to injury, while their livers produce more an...
Researchers found that hospital mortality increased significantly according to the Child-Pugh classification, with a mortality rate of 10 percent for those with class A, 18 percent for those with class B, and 67 percent for those with class C. Postoperative complications were also higher in class B and C than in class A.
A new algorithm developed by Carnegie Mellon University researchers can create matches for three- and four-way kidney exchanges, increasing the efficiency of kidney exchanges. The algorithm has already been used by the Alliance for Paired Donation, a kidney exchange program, to identify potential transplants and improve transplant rates.
A recent study published in Liver Transplantation found that more than 78 percent of living right liver donors experienced post-operative complications, with most being minor but some life-threatening. The modified Clavien system was used to classify the severity of complications, with Grade I being minor and Grade V resulting in death.
UPMC has started a study using the VentrAssist LVAD, a mechanical blood pump to assist the heart in pumping blood around the body. The study aims to enroll 30 patients for a multi-center feasibility trial to explore its safety and effectiveness as a bridge to transplantation.
Researchers have successfully transplanted human gut microbes into mice, providing insights into the metabolic system and its effects on fat absorption and digestion. The study found that gut microbes influence bile acid metabolism and fiber breakdown, impacting overall health.
A recent study found that obesity is a significant barrier to living kidney donation among African Americans, with over 30% of black donors excluded due to obesity. Social reasons, including failure to complete the donor evaluation process, also contribute to the low rates of donation.
A recent study found that CT and MRI are highly accurate in determining optimal candidates for liver transplantation in patients with cirrhosis. The study demonstrated agreement between radiology and pathology staging in 96.5-97.5% of patients, supporting the use of imaging tools in candidate selection.
Contrast-enhanced ultrasound (CE-US) is highly accurate in identifying vascular and biliary complications after liver transplant, affecting up to 43.5% of patients. CE-US can accurately detect complications such as hepatic artery thrombosis, portal vein stenosis, and bile leaks.
A study of HCV patients post-liver transplantation reveals stagnant survival rates, contrasting with improving outcomes for non-HCV recipients. Researchers analyzed a large sample of US liver transplant data between 1991 and 2001, finding HCV patients had lower 3-year survival rates and no improvement in survival over time.
A study of hospitalized patients with cirrhosis and complications of portal hypertension reveals significant racial disparities in treatment, with African-American and Hispanic patients less likely to receive palliative shunts, liver transplants, and prompt endoscopy. These disparities were independent of health insurance status.
A 4-step process can be completed quickly and efficiently to assess potential living liver donors. Despite challenges, the process results in a significant proportion of donors undergoing successful transplantation, emphasizing the importance of careful workup and informed consent.
A new implantable device has shown to effectively maintain heart function in transplant-listed patients, improving survival rates and quality of life. The study also explores the benefits of diuretic therapies in supporting left ventricular function, with promising results.
The study found that survival rates for patients with hepatitis B who need liver transplants are similar between those with and without hepatocellular carcinoma (HCC). Despite the higher likelihood of transplantation, 5-year survival rates were comparable between the two groups. The findings suggest that antiviral therapy may have bene...
Researchers used gene-expression profiling to identify donors with a strong reaction against recipient cells, leading to increased risk of graft-versus-host disease. Accurate MHC haplotype matching reduced mismatching-related risks.
A study found that liver transplant patients with a history of obesity, impaired fasting glucose, and hepatitis C infection are at increased risk of developing new-onset diabetes mellitus. The risk factors also include the use of certain immunosuppressants and cardiovascular risk factors.
The University of Minnesota's Maryam Valapour has received a grant to analyze the ethical and policy issues surrounding living-donor lung transplants. She aims to identify factors that encourage and discourage wider use of this procedure, which is currently less common than deceased donor transplants.
Researchers developed a treatment using mechanical Left Ventricular Assist Devices (LVADs) and certain drug therapies to shrink enlarged hearts and enable normal function. The therapy improved quality of life in 88% of patients who received the full combination, with nearly all recovering from heart disease five years later.
Researchers have identified a novel genetic change causing aHUS, a chronic disease that causes kidney failure and can be inherited. The mutation affects the factor H protein, which is crucial for controlling the complement system, and may lead to poor transplant outcomes.
The Edmonton Protocol clinical trial demonstrates islet transplantation as a promising procedure for managing severe Type 1 Diabetes, achieving insulin independence in 44% of recipients and improved blood sugar control. However, long-term sustainability varies, highlighting the need for continued research into this therapy.
Research published in Gut found that female liver transplant recipients live an average of 22 years after the procedure, compared to 18 years for men. The study analyzed data from over 2,700 patients and found that younger people tend to have longer life expectancy but also lose more years of life due to transplantation.
A multicenter clinical trial confirmed the Edmonton Protocol's ability to safely promote long-term stabilization of blood sugar levels in 'brittle' diabetes patients, with some achieving insulin independence. Investigators also reported improved measures of blood glucose control and reversal of hypoglycemic unawareness.
A new strategy called domino paired donation can match kidneys from living non-directed donors to recipients who have a willing but incompatible donor. This approach has the potential to increase both quantitative and qualitative benefit of each LND donation, leading to more transplants accomplished.
A study by the University of Alberta and other institutions found that living kidney donors incur various costs, including travel and accommodation expenses, lost income, and physical limitations after surgery. These costs can range from $837 to $28,900 per donor and may lead to financial burdens and disincentives for potential donors.
Research shows a survival rate of 84% in third year follow-up, greatly reduced infections and lymphoma-like disorders, with improved quality of life for children after transplantation.
A study found that a combination of pegylated interferon and ribavirin achieved better results than standard therapy in patients with recurrent hepatitis C after liver transplantation. The treatment was more effective, especially when patients showed an early decline in viral load.
The face transplant technique has achieved an aesthetic outcome better than conventional methods, allowing the patient to regain ability to chew food and improve speech. However, substantial lifelong immunosuppression is required to prevent rejection, posing potential risks.
A study of nearly 600 female heart failure patients revealed that women had better outcomes with lower VO2 levels and less need for a heart transplant. The results challenge the current 'gold standard' for assessing treatment options, highlighting the importance of considering gender differences in heart failure management.
A study of 96 liver transplant patients found that 66% were fatigued, with physical fatigue and reduced activity being the primary concerns. Rehabilitation programs focusing on improving activity patterns and physical fitness may help alleviate fatigue after liver transplantation.
A study found that patients with HIV-HBV coinfection can successfully undergo liver transplantation without progression of viral disease, even in the setting of lamivudine resistance. Controlling HBV is crucial for survival, and ongoing monitoring will be essential to minimize liver-related complications.
A University of Alberta study found that older donor hearts are just as good as younger ones, with similar survival rates at the end of 10 years. Despite initial risks, such as increased mortality within 30 days and pretransplant diabetes, long-term outcomes were comparable.
Researchers at Children's Hospital in Pennsylvania have successfully performed liver transplants on patients with maple syrup urine disease (MSUD), a rare genetic disorder that causes amino acid accumulation. The study shows improved metabolic stability and reduced risk of brain swelling, stroke, and learning disabilities.
Researchers developed a non-invasive method to measure indocyanine green elimination, correlating with traditional liver function tests. The test predicted poor outcomes and may improve liver transplant outcomes by guiding clinical management.
Researchers at UCSB have discovered that rapamycin, a widely available immunosuppressant, can strongly reduce cyst growth in kidneys affected by polycystic kidney disease (PKD). The treatment was found to shrink cysts and retain kidney function in mice with PKD.
Researchers found that PROCAM and SCORE accurately predict cardiovascular risk in liver transplant patients, outperforming the Framingham risk score. The study analyzed data from 303 patients who received a liver transplant between 1988 and 1994.
A study by Dr. Harris has shown promising results for the SAFE System, a hair replacement surgery that reduces trauma and increases accessibility for African-American and elderly patients. The procedure also boasts virtually pain-free surgery, faster recovery time, and increased efficiency for physicians.
Researchers found that HCV RNA levels decrease rapidly during and after transplantation, then increase within days. The study suggests the liver is the primary site of viral replication, with a non-hepatic source contributing to some viral production.
A study of 50 patients with treatment-resistant lupus found an overall 5-year survival rate of 84% after autologous hematopoietic stem cell transplantation (HSCT). The longest continuous duration of remission was 7.5 years, with a 2% treatment-related death rate.
Research suggests Cyclosporine may be a beneficial primary immunosuppression for HCV patients, achieving better antiviral effects than Tacrolimus when combined with interferon. However, the use of Cyclosporine also increases the risk of infections and hepatitis complications.
Researchers studied 18 cystic fibrosis patients who experienced variceal bleeding and found that most could manage without liver replacement. The study's findings challenge the common assumption that CF patients with bleeding complications are poor candidates for liver transplants.
End-stage renal disease (ESRD) has increased in Canada and worldwide since 1980, with 25,000 Canadians receiving life-sustaining treatment. Despite its benefits, there is a marked regional disparity in transplant rates, highlighting the need for tailored guidelines on eligibility across various criteria.
A study found that HIV-positive patients with end-stage liver disease have a high risk of early death, likely due to weakened immune systems. The authors recommend closer monitoring and earlier transplant evaluation for these patients to minimize the risk.
The pediatric acute liver study, directed from Children's, will investigate the causes and treatment of acute liver failure in children. The three aspects of the study include developing a registry, therapeutic clinical trials, and basic research into genetic causes of the condition.
A study published in the Journal of Clinical Oncology found that patients who underwent stem-cell transplantation have similar rates of hospitalization, diseases, and psychological health as those who did not receive a transplant. However, they reported higher incidence of musculoskeletal problems and poor long-term sexual health.
Researchers discovered that low doses of azithromycin can halt and reverse lung function decline in the majority of lung transplant patients with BOS, offering a new hope for treatment.
Mayo Clinic's new treatment protocol combining radiation therapy, chemotherapy, and liver transplantation has significantly improved the five-year survival rate for patients with bile duct cancer to 82%. The treatment enables surgeons to remove the entire liver and obtain better tumor clearance.
Research suggests that high blood lactate levels can accurately predict a poor outcome in patients with fulminant hepatic failure (FHF). The study examined the relationship between serum phosphate and lactate levels in FHF patients, finding that lactate levels were significantly higher in those who died or underwent a transplant.
Researchers found that alendronate, combined with calcium and vitamin D, significantly prevented further bone loss in liver transplant patients for four months after the procedure. After three years, patients with osteopenia or osteoporosis showed improved BMD despite not reaching normal levels.
A recent study found a significant percentage of patients who received a liver transplant due to alcoholic liver disease also used tobacco post-transplant. The majority of smokers resumed their habit quickly and showed increased consumption over time, highlighting the need for more stringent monitoring and intervention.
A study of 11 patients with non-Hodgkin's lymphoma who have failed standard chemotherapy found that Zevalin was effective in inducing partial and complete responses in three patients. The treatment was well-tolerated, with side effects including thrombocytopenia and neutropenia.
Research finds that high cyclosporine levels are associated with increased risk of hepatocellular carcinoma (HCC) recurrence after liver transplantation. The study suggests tailoring immunosuppressive schedules to individual patients based on their tumor biology, and recommends minimizing exposure to cyclosporine to prevent recurrence.
A study of 752 French patients found that shorter graft ischemic times were associated with improved long-term survival after single or double lung transplantation. The median ischemic time was 240 minutes, and a cutoff time of 330 minutes was identified as best discriminating between survivors and non-survivors.
A study of liver transplant patients with hepatitis C found that donor age does not impact long-term survival rates. Instead, maintenance azathioprine was associated with improved overall and 3-month survival rates, suggesting a complex relationship between immunosuppression and disease progression.